Treatment patterns in disease-modifying therapy for patients with multiple sclerosis in the United States.

@article{Bonafede2013TreatmentPI,
  title={Treatment patterns in disease-modifying therapy for patients with multiple sclerosis in the United States.},
  author={Machaon M K Bonafede and Barbara H. Johnson and Mad{\'e} Wenten and Crystal Watson},
  journal={Clinical therapeutics},
  year={2013},
  volume={35 10},
  pages={1501-12}
}
BACKGROUND Patients with multiple sclerosis (MS) whose disease activity is inadequately controlled with a platform therapy (interferon beta or glatiramer acetate [GA]) may switch to another platform therapy or escalate therapy to natalizumab or fingolimod, which were approved in the US in 2006 and 2010, respectively. OBJECTIVE The objective of this study was to describe treatment patterns in patients with multiple sclerosis (MS) in the United States who were followed for 2 years after… CONTINUE READING

From This Paper

Figures, tables, results, connections, and topics extracted from this paper.
8 Extracted Citations
0 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.

Similar Papers

Loading similar papers…